{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:22:05Z","timestamp":1791976925574,"version":"4.4.0"},"reference-count":195,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005681","name":"Genesis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejca.2022.03.043","type":"journal-article","created":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T11:15:21Z","timestamp":1655637321000},"page":"203-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"special_numbering":"C","title":["Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline \u2013 Update 2022"],"prefix":"10.1016","volume":"171","author":[{"given":"Marie-L\u00e9a","family":"Gauci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-653X","authenticated-orcid":false,"given":"Jurgen C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Del Marmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-7883","authenticated-orcid":false,"given":"Ana M.","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-2556","authenticated-orcid":false,"given":"Maria C.","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0922-2665","authenticated-orcid":false,"given":"Fabio","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-9587","authenticated-orcid":false,"given":"Axel","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kelleners-Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-0964","authenticated-orcid":false,"given":"Aimilios","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Moreno-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-2951","authenticated-orcid":false,"given":"Giovanni","family":"Pellacani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6500-3507","authenticated-orcid":false,"given":"Philippe","family":"Saiag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stratigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-4955","authenticated-orcid":false,"given":"Iris","family":"Zalaudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-780X","authenticated-orcid":false,"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-7290","authenticated-orcid":false,"given":"C\u00e9leste","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2022.03.043_bib1","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.ejca.2015.06.131","article-title":"Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline","volume":"51","author":"Lebbe","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib2","first-page":"562","article-title":"S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) \u2013 update 2018","volume":"17","author":"Becker","year":"2019","journal-title":"JDDG - J Ger Soc Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib3","series-title":"Merkel Cell Carcinoma Version 1.2021","author":"Schmults","year":"2021"},{"key":"10.1016\/j.ejca.2022.03.043_bib4","article-title":"AGREE II: Advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.ejca.2022.03.043_bib5","first-page":"1","article-title":"\u201cThe Oxford 2011 levels of evidence\u201d","volume":"1","author":"Paul","year":"2011","journal-title":"Oxford Cent Evidence-Based Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/CCO.0000000000000608","article-title":"Immunobiology of Merkel cell carcinoma","volume":"32","author":"Samimi","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/jid.2010.58","article-title":"Incidence and trends of cutaneous malignancies in The Netherlands, 1989-2005","volume":"130","author":"Holterhues","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/jid.2013.304","article-title":"Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence","volume":"134","author":"Eisemann","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib9","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/ajd.13131","article-title":"Trends in the incidence of Merkel cell carcinoma in Victoria, Australia, between 1986 and 2016","volume":"61","author":"Garbutcheon-Singh","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2011.10493.x","article-title":"Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival","volume":"165","author":"Girschik","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.13782","article-title":"Epidemiology of Merkel cell carcinoma in New Zealand: a population-based study","volume":"173","author":"Robertson","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib13","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1111\/ajd.13023","article-title":"Epidemiology and survival of Merkel cell carcinoma in New Zealand: a population-based study between 2000 and 2015 with international comparison","volume":"60","author":"Lee","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib14","first-page":"1","article-title":"Assessment of age, period, and birth cohort effects and trends in merkel cell carcinoma incidence in the United States","author":"Jacobs","year":"2020","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","article-title":"Merkel cell carcinoma: current US incidence and projected increases based on changing demographics","volume":"78","author":"Paulson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/000313481508100819","article-title":"Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States","volume":"81","author":"Fitzgerald","year":"2015","journal-title":"Am Surg"},{"key":"10.1016\/j.ejca.2022.03.043_bib17","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/jdv.14798","article-title":"Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey","volume":"32","author":"Fondain","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2022.03.043_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canep.2016.09.001","article-title":"Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: a population-based study","volume":"45","author":"Rubi\u00f3-Casadevall","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2022.03.043_bib19","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.13869","article-title":"Merkel cell carcinoma in Scotland 2000-10","volume":"173","author":"Samuel","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejca.2010.11.002","article-title":"Epidemiology and survival of Merkel cell carcinoma in The Netherlands. A population-based study of 808 cases in 1993-2007","volume":"47","author":"Reichgelt","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/jdv.13698","article-title":"Merkel cell carcinoma incidence is increasing in Sweden","volume":"30","author":"Zaar","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2022.03.043_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejca.2011.06.001","article-title":"Merkel cell carcinoma - a population-based epidemiological study in Finland with a clinical series of 181 cases","volume":"48","author":"Kukko","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ijc.31860","article-title":"Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France","volume":"144","author":"Kieny","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib24","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jdv.13828","article-title":"Merkel cell carcinoma: rising incidence in the east of england","volume":"30","author":"Goon","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2022.03.043_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/2000656X.2011.613233","article-title":"Rising incidence of Merkel cell carcinoma","volume":"45","author":"Lyhne","year":"2011","journal-title":"J Plast Surg Hand Surg"},{"key":"10.1016\/j.ejca.2022.03.043_bib26","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaad.2018.10.045","article-title":"Merkel cell carcinoma incidence, trends, and survival rates among adults aged \u226550 years from United States Cancer Statistics","volume":"80","author":"Freeman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib27","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1245\/s10434-016-5266-4","article-title":"Analysis of prognostic factors from 9387 merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system","volume":"23","author":"Harms","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2018.02.003","article-title":"The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment","volume":"94","author":"Stang","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0190-9622(03)02108-X","article-title":"Epidemiology of primary Merkel cell carcinoma in the United States","volume":"49","author":"Agelli","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199810223391715","article-title":"Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation","volume":"339","author":"Lunder","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","article-title":"Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study","volume":"37","author":"Albores-Saavedra","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jamadermatol.2013.8116","article-title":"Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma","volume":"150","author":"Asgari","year":"2014","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.2012.09087.x","article-title":"Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumor","volume":"157","author":"Tadmor","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2022.03.043_bib34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","article-title":"Merkel cell carcinoma and multiple primary cancers","volume":"15","author":"Howard","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2022.03.043_bib35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.2011.34.9605","article-title":"Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and merkel cell carcinoma in a SEER population-based study","volume":"30","author":"Brewer","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/QAD.0b013e3283213046","article-title":"Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States","volume":"23","author":"Lanoy","year":"2009","journal-title":"Aids"},{"key":"10.1016\/j.ejca.2022.03.043_bib37","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/ijc.24931","article-title":"Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults","volume":"126(7)","author":"Lanoy","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of Merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.043_bib39","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/bjd.18218","article-title":"Merkel cell carcinoma in kidney transplant recipients in Ireland 1964\u20132018","volume":"181","author":"Keeling","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib40","first-page":"30","article-title":"Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma","volume":"12","author":"Starrett","year":"2020","journal-title":"Genome\u00a0Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00020","article-title":"Merkel cell polyoma viral load and intratumoral CD8+ lymphocyte infiltration predict overall survival in patients with Merkel cell carcinoma","volume":"9","author":"Von Der Gr\u00fcn","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jid.2016.10.028","article-title":"Polyomavirus-negative merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection","volume":"137","author":"Moshiri","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-019-09601-5","article-title":"Prognostic impact of MCPyV and TIL subtyping in merkel cell carcinoma: evidence from a large European cohort of 95 patients","volume":"31","author":"Ricci","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib44","first-page":"1","article-title":"Improved survival in women versus men with Merkel cell carcinoma","author":"Tam","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib45","doi-asserted-by":"crossref","first-page":"20160276","DOI":"10.1098\/rstb.2016.0276","article-title":"Merkel cell polyomavirus and Merkel cell carcinoma","volume":"372","author":"DeCaprio","year":"2017","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.ejca.2022.03.043_bib46","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/jid.2014.446","article-title":"Merkel cell polyomavirus small T antigen is oncogenic in transgenic mice","volume":"135","author":"Verhaegen","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib47","doi-asserted-by":"crossref","first-page":"2129251630","DOI":"10.1146\/annurev-pathmechdis-012419-032817","article-title":"Molecular pathogenesis of merkel cell carcinoma","volume":"16","author":"DeCaprio","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib48","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3390\/cancers12071774","article-title":"Merkel cell polyomavirus and merkel cell carcinoma","volume":"12","author":"Pietropaolo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.03.043_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2019.00451","article-title":"Histogenesis of Merkel cell carcinoma: a comprehensive review","volume":"9","author":"Kervarrec","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12105-017-0859-1","article-title":"Merkel cell carcinoma of the buccal mucosa and lower lip","volume":"12","author":"Islam","year":"2018","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.det.2019.06.002","article-title":"Updates on merkel cell carcinoma","volume":"37","author":"Emge","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ejca.2022.03.043_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaad.2017.12.001","article-title":"Merkel cell carcinoma: an update and review","volume":"78","author":"Coggshall","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib54","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/cup.12966","article-title":"Intraepidermal Merkel cell carcinoma: a case series of a rare entity with clinical follow up","volume":"44","author":"Jour","year":"2017","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib55","first-page":"238","article-title":"Dermoscopy and reflectance confocal microscopy of intraepidermal Merkel cell carcinoma","volume":"62(2)","author":"Navarrete-Dechent","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000337411","article-title":"Dermoscopy of merkel cell carcinoma","volume":"224","author":"Dalle","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib57","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ajd.12074","article-title":"Dermoscopy of uncommon skin tumors","volume":"55","author":"Lallas","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib58","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bjd.12376","article-title":"Clinical and dermoscopic characteristics of Merkel cell carcinoma","volume":"169","author":"Jalilian","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib59","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2022.03.043_bib60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","article-title":"Merkel cell carcinoma: an update and review: current and future therapy","volume":"78","author":"Tello","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humpath.2018.07.022","article-title":"Immunohistochemical profiles of different subsets of Merkel cell carcinoma","volume":"82","author":"Pasternak","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41379-018-0155-y","article-title":"Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas","volume":"32","author":"Kervarrec","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2022.03.043_bib63","unstructured":"AJCC Cancer staging manual. 8th ed.. In: Amin MB, Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., Sullivan, D.C., Jessup, J.M., Brierley, J.D., Gaspar, L.E., Schilsky, R.L., Balch, n.d."},{"key":"10.1016\/j.ejca.2022.03.043_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/cancers13020265","article-title":"Sex differences in overall survival and the effect of radiotherapy in merkel cell carcinoma\u2014a retrospective analysis of A Swedish cohort","volume":"13","author":"Bj\u00f6rn Andtback","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.03.043_bib65","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/1754-9485.13039","article-title":"Immune status and the efficacy of radiotherapy on overall survival for patients with localized Merkel cell carcinoma: an analysis of the National Cancer Database","volume":"64","author":"Yusuf","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib66","first-page":"844","article-title":"Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): a multi-institutional cohort study","volume":"221(4)","author":"Bleicher","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejca.2022.03.043_bib67","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/lary.23222","article-title":"Merkel cell carcinoma: Identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data","volume":"122","author":"Smith","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejca.2022.03.043_bib68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib69","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1245\/s10434-012-2509-x","article-title":"Increasing tumor thickness is associated with recurrence and poorer survival in patients with merkel cell carcinoma","volume":"19","author":"Lim","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib70","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/cncr.29452","article-title":"Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma","volume":"121","author":"Smith","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib71","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SLA.0b013e31822c5fc1","article-title":"Five hundred patients with merkel cell carcinoma evaluated at a single institution","volume":"254","author":"Fields","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2022.03.043_bib72","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1158\/1078-0432.CCR-11-3020","article-title":"Tumor infiltrating immune cells and outcome of merkel cell carcinoma: a population-based study","volume":"18","author":"Sihto","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib73","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1158\/1078-0432.CCR-16-0392","article-title":"Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma","volume":"22","author":"Feldmeyer","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib74","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1158\/1078-0432.CCR-20-0864","article-title":"Virus-positive merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers","volume":"27(9)","author":"Harms","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jid.2016.08.015","article-title":"Shared oncogenic pathways implicated in both virus-positive and UV-induced merkel cell carcinomas","volume":"137","author":"Gonz\u00e1lez-Vela","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib76","article-title":"Merkel cell carcinoma outcomes: does AJCC8 underestimate survival?","volume":"27","author":"Farley","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.142.6.685","article-title":"Sentinel lymph node biopsy for evaluation and treatment of patients with merkel cell carcinoma","volume":"142","author":"Gupta","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","article-title":"Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system","volume":"63","author":"Lemos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.14240","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases","volume":"174","author":"Gunaratne","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaad.2019.12.072","article-title":"Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma","volume":"84","author":"Nguyen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib81","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1245\/s10434-020-08587-3","article-title":"Patterns of metastasis in merkel cell carcinoma","volume":"28","author":"Song","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib82","article-title":"Clinical features and prognosis of merkel cell carcinoma in elderly patients","volume":"26","author":"Xia","year":"2020","journal-title":"Med Sci Mon Int Med J Exp Clin Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib83","first-page":"330","article-title":"Clinical benefit of baseline imaging in merkel cell carcinoma: analysis of 584 patients","volume":"84(2)","author":"Singh","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib84","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-018-0423-3","article-title":"18F-FDG and 68Ga-somatostatin analogs PET\/CT in patients with Merkel cell carcinoma: a comparison study","volume":"8","author":"Taralli","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-268","article-title":"Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging","volume":"14","author":"Buder","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib86","article-title":"High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma","author":"Akaike","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib87","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/cam4.2781","article-title":"Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance","volume":"9","author":"Lewis","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib88","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cncr.30475","article-title":"Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study","volume":"123","author":"Paulson","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib89","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-10-2128","article-title":"Antibodies to Merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in Merkel cell carcinoma patients","volume":"70","author":"Paulson","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib90","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bjd.14313","article-title":"Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma","volume":"174","author":"Samimi","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib91","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaad.2018.10.001","article-title":"Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions","volume":"82","author":"Yan","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib92","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamadermatol.2021.0247","article-title":"Association between surgical margins larger than 1 cm and overall survival in patients with merkel cell carcinoma","volume":"157","author":"Andruska","year":"2021","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib93","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.20647","article-title":"Predictors of survival and recurrence in the surgical treatment of Merkel cell carcinoma of the extremities","volume":"95","author":"Senchenkov","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaad.2017.09.049","article-title":"Utilization patterns and survival outcomes after wide local excision or Mohs micrographic surgery for Merkel cell carcinoma in the United States, 2004-2009","volume":"78","author":"Shaikh","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib95","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2018.01.041","article-title":"Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database","volume":"79","author":"Singh","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib96","article-title":"Relative survival analysis in patients with stage I-II Merkel cell carcinoma treated with Mohs micrographic surgery or wide local excision","author":"Su","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib97","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2012.09.036","article-title":"Prognostic factors in Merkel cell carcinoma: analysis of 240 cases","volume":"68","author":"Tarantola","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib98","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jaad.2020.07.079","article-title":"Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: analysis of 188 cases of localized disease and proposed management algorithm","volume":"84","author":"Tarabadkar","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1245\/s10434-015-4812-9","article-title":"Radiotherapy and conservative surgery in the locoregional management of merkel cell carcinoma: the British columbia cancer agency experience","volume":"23","author":"Harrington","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.03.043_bib100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jaad.2020.11.038","article-title":"Narrow resection margins are not associated with mortality or recurrence in patients with Merkel cell carcinoma: a retrospective study","volume":"84","author":"Jaouen","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib101","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1245\/s10434-018-6688-y","article-title":"Resection margins in merkel cell carcinoma: is a 1-cm margin wide enough?","volume":"25","author":"Perez","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib102","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1200\/JCO.2005.02.329","article-title":"Merkel cell carcinoma: prognosis and treatment of patients from a single institution","volume":"23","author":"Allen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib103","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/1346-8138.12072","article-title":"Sentinel lymph node in Merkel cell carcinoma: to biopsy or not to biopsy?","volume":"40","author":"Sattler","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib104","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2019.03.027","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: predictors of sentinel lymph node positivity and association with overall survival","volume":"81","author":"Conic","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib105","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1245\/s10434-013-3434-3","article-title":"Sentinel lymph node biopsy is associated with improved survival in merkel cell carcinoma","volume":"21","author":"Kachare","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib106","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.6004\/jnccn.2016.0134","article-title":"Merkel cell carcinoma: a population analysis on survival","volume":"14","author":"Sridharan","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejca.2022.03.043_bib107","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1245\/s10434-011-1662-y","article-title":"Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution","volume":"18","author":"Fields","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2017.10.005","article-title":"Sentinel lymph node biopsy in Merkel cell carcinoma: the Mayo Clinic experience of 150 patients","volume":"27","author":"Sims","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib109","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/annonc\/mdw035","article-title":"Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy","volume":"27","author":"Servy","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/489536","article-title":"Prognostic significance of sentinel lymph node mapping in merkel cell carcinoma: systematic review and meta-analysis of prognostic studies","volume":"2014","author":"Sadeghi","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejca.2022.03.043_bib111","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1245\/s10434-018-7072-7","article-title":"Completion lymph node dissection or radiation therapy for sentinel node metastasis in merkel cell carcinoma","volume":"26","author":"Lee","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib112","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjsurg.2020.02.018","article-title":"Completion lymph node dissection for Merkel cell carcinoma","volume":"220","author":"Cramer","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejca.2022.03.043_bib113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1245\/s10434-018-6810-1","article-title":"Management of sentinel lymph node metastasis in merkel cell carcinoma: completion lymphadenectomy, radiation, or both?","volume":"26","author":"Perez","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib114","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0360-3016(94)00610-W","article-title":"Radiation sensitivity of Merkel cell carcinoma cell lines","volume":"32","author":"Leonard","year":"1995","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib115","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.ijrobp.2011.05.028","article-title":"The essential role of radiotherapy in the treatment of merkel cell carcinoma: a study from the rare cancer Network","volume":"81","author":"Ghadjar","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib116","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1748-717X-7-171","article-title":"Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma","volume":"7","author":"Kang","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib117","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1245\/s10434-016-5293-1","article-title":"Radiation therapy is associated with improved outcomes in merkel cell carcinoma","volume":"23","author":"Strom","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib118","doi-asserted-by":"crossref","first-page":"djw042","DOI":"10.1093\/jnci\/djw042","article-title":"Adjuvant radiation therapy and chemotherapy in merkel cell carcinoma: survival analyses of 6908 cases from the national cancer data base","volume":"108","author":"Bhatia","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.043_bib119","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2006.07.9319","article-title":"Adjuvant radiation therapy is associated with improved survival in merkel cell carcinoma of the skin","volume":"25","author":"Mojica","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib120","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/jso.25090","article-title":"Merkel cell carcinoma: clinical outcome and prognostic factors in 351 patients","volume":"117","author":"van Veenendaal","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib121","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.adro.2016.10.003","article-title":"Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck","volume":"1","author":"Takagishi","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib122","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2019.02.015","article-title":"Adjuvant radiotherapy for Merkel cell carcinoma: a systematic review and meta-analysis","volume":"134","author":"Petrelli","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib123","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/annonc\/mdr318","article-title":"Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study","volume":"23","author":"Jouary","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib124","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.ijrobp.2010.04.061","article-title":"Merkel cell carcinoma: 27-year experience at the peter MacCallum cancer Centre","volume":"80","author":"Hui","year":"2011","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hed.24527","article-title":"Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck","volume":"39","author":"Strom","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2022.03.043_bib126","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/cncr.24919","article-title":"Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma","volume":"116","author":"Fang","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib127","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamadermatol.2017.2176","article-title":"Identifying an optimal adjuvant radiotherapy dose for extremity and trunk merkel cell carcinoma following resection","volume":"153","author":"Patel","year":"2017","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.ejca.2022.03.043_bib128","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hed.24776","article-title":"Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection","volume":"39","author":"Patel","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2022.03.043_bib129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ajd.12263","article-title":"Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients","volume":"56","author":"Veness","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib130","article-title":"Outcome of early stage Merkel carcinoma treated by exclusive radiation : a study of 53 patients","volume":"1\u20139","author":"Dubois","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib131","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/CCO.0000000000000363","article-title":"New developments in the biology and the treatment of metastatic Merkel cell carcinoma","volume":"29","author":"Terheyden","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib132","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2326-6066.CIR-13-0034","article-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival","volume":"1","author":"Lipson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib133","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-15-0059","article-title":"Antibody-dependent cellular cytotoxicity activity of a Novel Anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells","volume":"3","author":"Boyerinas","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ejca.2022.03.043_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2020-000674","article-title":"Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial","volume":"8","author":"D'Angelo","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib135","first-page":"1","article-title":"Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma a preplanned interim analysis of a clinical trial","volume":"4","author":"D'Angelo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib136","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1200\/JCO.18.01896","article-title":"Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy","volume":"37","author":"Nghiem","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib137","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib138","series-title":"Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1\/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC)","author":"Topalian","year":"2017"},{"key":"10.1016\/j.ejca.2022.03.043_bib139","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib140","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40425-017-0310-x","article-title":"Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after \u22651 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial","volume":"6","author":"Kaufman","year":"2018","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib141","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jitc-2019-000313","article-title":"Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program","volume":"8","author":"Walker","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib142","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2217\/fon-2017-0072","article-title":"Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma","volume":"13","author":"Nghiem","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib143","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib144","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2589::AID-CNCR15>3.0.CO;2-F","article-title":"Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma","volume":"85","author":"Voog","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib145","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.9527","article-title":"Adjuvant ipilimumab compared with observation in completely resected Merkel cell carcinoma (ADMEC): a randomized, multicenter DeCOG\/ADO study","volume":"36","author":"Becker","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib146","unstructured":"Nivolumab adjuvant (NCT02196961); ADMEC (DeCOG); Ph-II, open, randomized vs observation; www.clinicaltrials.gov [n.d]."},{"key":"10.1016\/j.ejca.2022.03.043_bib147","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1200\/JCO.20.00201","article-title":"Neoadjuvant nivolumab for patients with resectable Merkel cell carcinoma in the CheckMate 358 trial","volume":"38","author":"Topalian","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib148","first-page":"967","article-title":"Merkel cell carcinoma","volume":"58","author":"Nasseri","year":"2012","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ejca.2022.03.043_bib149","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.ejso.2017.07.015","article-title":"Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): a multicenter experience","volume":"43","author":"van Veenendaal","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib150","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1245\/s10434-017-6107-9","article-title":"Isolated limb infusion: a single-center experience with over 200 infusions","volume":"24","author":"O'Donoghue","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib151","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/cam4.458","article-title":"Single-fraction radiation therapy in patients with metastatic Merkel cell carcinoma","volume":"4","author":"Iyer","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib152","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1200\/JCO.2010.29.0635","article-title":"Treatment of cutaneous metastases of merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy","volume":"28","author":"Cotter","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/PPO.0b013e31829e3566","article-title":"Palliative treatment for in-transit cutaneous metastases of merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy","volume":"19","author":"Garibyan","year":"2013","journal-title":"Cancer J"},{"key":"10.1016\/j.ejca.2022.03.043_bib154","unstructured":"Schadendorf D, Larkin J, Postow M, Chiarion-sileni V, Gonzalez R, Rutkowski P, et\u00a0al. Efficacy and safety outcomes in patients with advanced melanoma (MEL) who discontinued treatment with nivolumab (NIVO) plus ipilimumab (IPI) due to toxicity Disclosures : Dirk Schadendorf , MD \u2022 Research funding from Merck and Bristol-Myers Squibb \u2022 n.d.:1\u201318."},{"key":"10.1016\/j.ejca.2022.03.043_bib155","first-page":"337","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejca.2022.03.043_bib156","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","article-title":"Practical assessment and management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology","volume":"36","author":"Mohile","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib157","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib158","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/annonc\/mdy228","article-title":"Addressing the quality of life needs of older patients with cancer: a SIOG consensus paper and practical guide","volume":"29","author":"Scott\u00e9","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib159","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib160","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","year":"2018"},{"key":"10.1016\/j.ejca.2022.03.043_bib161","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jpainsymman.2009.11.319","article-title":"A systematic review of topical treatments to control the odor of malignant fungating wounds","volume":"39","author":"da Costa Santos","year":"2010","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.ejca.2022.03.043_bib162","article-title":"Polyhexanide versus metronidazole for odor management in malignant (fungating) wounds","volume":"1","author":"Villela-Castro","year":"2018","journal-title":"J Wound, Ostomy Cont Nurs"},{"key":"10.1016\/j.ejca.2022.03.043_bib163","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1634\/theoncologist.9-5-561","article-title":"Management of bleeding in patients with advanced cancer","volume":"9","author":"Pereira","year":"2004","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib164","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41571-018-0103-2","article-title":"The biology and treatment of Merkel cell carcinoma: current understanding and research priorities","volume":"15","author":"Harms","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/mc.23190","article-title":"Polyomavirus-driven Merkel cell carcinoma: prospects for therapeutic vaccine development","volume":"59","author":"Tabachnick-Cherny","year":"2020","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ejca.2022.03.043_bib166","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/bjd.19021","article-title":"Sentinel lymph node positivity and overall survival in immunosuppressed patients with Merkel cell carcinoma: a national cohort study","volume":"183","author":"Song","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib167","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1093\/ndt\/gfp334","article-title":"Incidence of Merkel cell carcinoma in renal transplant recipients","volume":"24","author":"Koljonen","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejca.2022.03.043_bib168","first-page":"199","article-title":"Risk of rare cancers among solid organ transplant recipients","volume":"113","author":"D'Arcy","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2022.03.043_bib169","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jaad.2014.05.054","article-title":"Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation","volume":"71","author":"Arron","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib170","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2012.388","article-title":"Systemic immune suppression predicts diminished merkel cell carcinoma\u2013specific survival independent of stage","volume":"133","author":"Paulson","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ejca.2022.03.043_bib172","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(02)07668-7","article-title":"Merkel cell carcinoma and HIV infection","volume":"359","author":"Engels","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2022.03.043_bib173","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1002\/ijc.27376","article-title":"Kaposi sarcoma and Merkel cell carcinoma after autoimmune disease","volume":"131","author":"Hemminki","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib174","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.2016.391","article-title":"History of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection","volume":"116","author":"Sahi","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib175","first-page":"82","article-title":"Differential outcomes among immunosuppressed patients with Merkel cell carcinoma","volume":"42","author":"Cook","year":"2019","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"10.1016\/j.ejca.2022.03.043_bib176","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/cancers6031328","article-title":"Merkel cell carcinoma in immunosuppressed patients","volume":"6","author":"Ma","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2022.03.043_bib177","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2018.05.075","article-title":"Effect of patient immune status on the efficacy\u00a0of radiation therapy and recurrence-free survival among\u00a0805 patients with merkel cell carcinoma","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib178","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CCO.0000000000000505","article-title":"Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?","volume":"31","author":"De Bruyn","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib179","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib180","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002502","article-title":"Preserved renal allograft function and successful treatment of metastatic merkel cell cancer post nivolumab therapy","volume":"103","author":"Singh","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejca.2022.03.043_bib181","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000897","article-title":"Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients","volume":"8","author":"Leiter","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib182","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1093\/annonc\/mdx538","article-title":"Checkpoint blockade for metastatic melanoma and Merkel cell carcinoma in HIV-positive patients","volume":"28","author":"Heppt","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib183","first-page":"42","article-title":"Successful immunotherapy and irradiation in a HIV-positive patient with metastatic Merkel cell carcinoma","volume":"15","author":"Linge","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib184","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s40425-019-0771-1","article-title":"Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection","volume":"7","author":"Shah","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdcr.2020.11.020","article-title":"Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: a case series of 3 patients","volume":"8","author":"Park","year":"2021","journal-title":"JAAD Case Reports"},{"key":"10.1016\/j.ejca.2022.03.043_bib186","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2022.03.043_bib187","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib188","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2017.76.6691","article-title":"Sirolimus for secondary prevention of skin cancer in kidney transplant recipients: 5-year results","volume":"36","author":"Dantal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.03.043_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2018.03.602","article-title":"594 an integrated approach to predict and detect Merkel cell carcinoma recurrences","volume":"138","author":"Lachance","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2022.03.043_bib190","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdq366","article-title":"Merkel cell carcinoma","volume":"21","author":"Becker","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib191","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/fon-2020-0064","article-title":"Frequency and prognosis of metastasis to liver, lung, bone and brain from Merkel cell carcinoma","volume":"16","author":"Xia","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejca.2022.03.043_bib192","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.bjc.6605989","article-title":"Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia","volume":"104","author":"Bzhalava","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2022.03.043_bib193","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canep.2009.12.007","article-title":"Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study","volume":"34","author":"Koljonen","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ejca.2022.03.043_bib194","doi-asserted-by":"crossref","first-page":"26472","DOI":"10.18632\/oncotarget.4500","article-title":"Evaluating blood levels of neuron specific enolase, chromogranin A, and circulating tumor cells as Merkel cell carcinoma biomarkers","volume":"6","author":"Gaiser","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2022.03.043_bib195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1245\/s10434-020-08656-7","article-title":"The clinical utility of neuron-specific enolase (NSE) serum levels as a biomarker for merkel cell carcinoma (MCC)","volume":"28","author":"van Veenendaal","year":"2021","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:11Z","timestamp":1760733491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":195,"alternative-id":["S0959804922002532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.03.043","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline \u2013 Update 2022","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.03.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}